Literature DB >> 16547274

Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome.

Lisa R Young1, Michael T Borchers, Holly L Allen, Reta S Gibbons, Francis X McCormack.   

Abstract

Pulmonary inflammation, abnormalities in alveolar type II cell and macrophage morphology, and pulmonary fibrosis are features of Hermansky-Pudlak Syndrome (HPS). We used the naturally occurring "pearl" HPS2 mouse model to investigate the mechanisms of lung inflammation observed in HPS. Although baseline bronchoalveolar lavage (BAL) cell counts and differentials were similar in pearl and strain-matched wild-type (WT) mice, elevated levels of proinflammatory (MIP1gamma) and counterregulatory (IL-12p40, soluble TNFr1/2) factors, but not TNF-alpha, were detected in BAL from pearl mice. After intranasal LPS challenge, BAL levels of TNF-alpha, MIP1alpha, KC, and MCP-1 were 2- to 3-fold greater in pearl than WT mice. At baseline, cultured pearl alveolar macrophages (AMs) had markedly increased production of inflammatory cytokines. Furthermore, pearl AMs had exaggerated TNF-alpha responses to TLR4, TLR2, and TLR3 ligands, as well as increased IFN-gamma/LPS-induced NO production. After 24 h in culture, pearl AM LPS responses reverted to WT levels, and pearl AMs were appropriately refractory to continuous LPS exposure. In contrast, cultured pearl peritoneal macrophages and peripheral blood monocytes did not produce TNF-alpha at baseline and had LPS responses which were no different from WT controls. Exposure of WT AMs to heat- and protease-labile components of pearl BAL, but not WT BAL, resulted in robust TNF-alpha secretion. Similar abnormalities were identified in AMs and BAL from another HPS model, pale ear HPS1 mice. We conclude that the lungs of HPS mice exhibit hyperresponsiveness to LPS and constitutive and organ-specific macrophage activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547274      PMCID: PMC3783655          DOI: 10.4049/jimmunol.176.7.4361

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation.

Authors:  V Shotelersuk; E C Dell'Angelica; L Hartnell; J S Bonifacino; W A Gahl
Journal:  Am J Med       Date:  2000-04-01       Impact factor: 4.965

2.  Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1.

Authors:  M Brantly; N A Avila; V Shotelersuk; C Lucero; M Huizing; W A Gahl
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

3.  Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2.

Authors:  Marjan Huizing; Charles D Scher; Erin Strovel; Diana L Fitzpatrick; Lisa M Hartnell; Yair Anikster; William A Gahl
Journal:  Pediatr Res       Date:  2002-02       Impact factor: 3.756

4.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

5.  Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages.

Authors:  C Stamme; E Walsh; J R Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2000-12       Impact factor: 6.914

6.  Genomic structure of the mouse Ap3b1 gene in normal and pearl mice.

Authors:  L Feng; B W Rigatti; E K Novak; M B Gorin; R T Swank
Journal:  Genomics       Date:  2000-11-01       Impact factor: 5.736

7.  AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes.

Authors:  M Huizing; R Sarangarajan; E Strovel; Y Zhao; W A Gahl; R E Boissy
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

8.  A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8).

Authors:  Neil V Morgan; Shanaz Pasha; Colin A Johnson; John R Ainsworth; Robin A J Eady; Ban Dawood; Carole McKeown; Richard C Trembath; Jonathan Wilde; Steve P Watson; Eamonn R Maher
Journal:  Am J Hum Genet       Date:  2005-11-28       Impact factor: 11.025

9.  IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis.

Authors:  A R Kitching; P G Tipping; M Kurimoto; S R Holdsworth
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

10.  Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes.

Authors:  Y Nakatani; N Nakamura; J Sano; Y Inayama; N Kawano; S Yamanaka; Y Miyagi; Y Nagashima; C Ohbayashi; M Mizushima; T Manabe; M Kuroda; T Yokoi; O Matsubara
Journal:  Virchows Arch       Date:  2000-09       Impact factor: 4.064

View more
  32 in total

1.  Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease.

Authors:  Bernadette R Gochuico; Marjan Huizing; Gretchen A Golas; Charles D Scher; Maria Tsokos; Stacey D Denver; Melissa J Frei-Jones; William A Gahl
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

2.  Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis.

Authors:  Lisa R Young; Rajamouli Pasula; Peter M Gulleman; Gail H Deutsch; Francis X McCormack
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-15       Impact factor: 6.914

3.  Hermansky-Pudlak syndrome interstitial pneumonia: it's the epithelium, stupid!

Authors:  Poornima Mahavadi; Andreas Guenther; Bernadette R Gochuico
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

Review 4.  The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases.

Authors:  Shanna L Bowman; Jing Bi-Karchin; Linh Le; Michael S Marks
Journal:  Traffic       Date:  2019-06       Impact factor: 6.215

5.  Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease.

Authors:  Yang Zhou; Chuan Hua He; Daniel S Yang; Tung Nguyen; Yueming Cao; Suchitra Kamle; Chang-Min Lee; Bernadette R Gochuico; William A Gahl; Barry S Shea; Chun Geun Lee; Jack A Elias
Journal:  J Immunol       Date:  2018-02-02       Impact factor: 5.422

6.  Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Elena N Atochina-Vasserman; Sandra R Bates; Peggy Zhang; Helen Abramova; Zhenguo Zhang; Linda Gonzales; Jian-Qin Tao; Bernadette R Gochuico; William Gahl; Chang-Jiang Guo; Andrew J Gow; Michael F Beers; Susan Guttentag
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

7.  Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages.

Authors:  Huixing Wu; Takuji Suzuki; Brenna Carey; Bruce C Trapnell; Francis X McCormack
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

Review 8.  Approaches to Evaluate Lung Inflammation in Translational Research.

Authors:  David K Meyerholz; Jessica C Sieren; Amanda P Beck; Heather A Flaherty
Journal:  Vet Pathol       Date:  2017-08-16       Impact factor: 2.221

Review 9.  Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.

Authors:  Glenn W Vicary; Yeidyly Vergne; Alberto Santiago-Cornier; Lisa R Young; Jesse Roman
Journal:  Ann Am Thorac Soc       Date:  2016-10

10.  The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome.

Authors:  Lisa R Young; Peter M Gulleman; James P Bridges; Timothy E Weaver; Gail H Deutsch; Timothy S Blackwell; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2012-10-04       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.